Temple Lung Center
Philadelphia, Pennsylvania 19140
2 studies enrolling now · 12 studies all time
What they study most
COPD, Chronic Obstructive Pulmonary Disease, Emphysema, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Interstitial Lung Diseases, MAC Lung Disease, Mycobacterium Infections, Nontuberculous, Poor Sleep Quality, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Studies at this site
- A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases — Recruiting now
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) — Recruiting now
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis — Completed
- ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension — Stopped early
- Evaluation of the Safety and Efficacy of TLD in Patients with COPD — Running, not enrolling
- A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
- Acthar Gel in Participants With Pulmonary Sarcoidosis — Completed
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
- Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis — Completed
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument — Completed
- REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management — Completed
- Effect of Symbicort on Sleep Quality in Patients With Emphysema — Status unconfirmed